PGNY Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
341.3M
-2.6%
350.5M
+6.7%
328.5M
+3.2%
318.4M
+1.6%
313.3M
Cost of Revenue
257.5M
-1.4%
261.2M
+6.4%
245.4M
+1.6%
241.5M
+0.4%
240.5M
Gross Profit
83.7M
-6.2%
89.3M
+7.5%
83.1M
+8.1%
76.9M
+5.6%
72.8M
Operating Expenses
48.6M
-1.5%
49.3M
+3.4%
47.7M
-22.7%
61.7M
+20.2%
51.3M
R&D
0
0
0
0
0
SG&A
48.6M
-1.5%
49.3M
+3.4%
47.7M
-22.7%
61.7M
+20.2%
51.3M
Operating Income
35.2M
-12.1%
40.0M
+13.1%
35.4M
+132.4%
15.2M
-29.3%
21.5M
EBITDA
37.3M
-10.3%
41.6M
+12.9%
36.9M
+122.2%
16.6M
-27.2%
22.8M
Net Income
26.3M
-6.4%
28.1M
+15.8%
24.2M
+94.1%
12.5M
-9.9%
13.9M
EPS (Basic)
$0.34
-5.6%
$0.36
+20.0%
$0.30
+100.0%
$0.15
-6.3%
$0.16
EPS (Diluted)
$0.32
-5.9%
$0.34
+17.2%
$0.29
+107.1%
$0.14
-6.7%
$0.15
Shares (Diluted)
81.2M
-1.2%
82.1M
-3.1%
84.8M
-5.3%
89.5M
-0.8%
90.2M
Progyny (PGNY) — Financials